Premium
Regulation of Adhesion Molecules: A New Target for the Treatment of Chronic Venous Insufficiency
Author(s) -
VERBEUREN TONY J.,
BOUSKELA ELIETE,
COHEN RICHARD A.,
VANHOUTTE PAUL M.
Publication year - 2000
Publication title -
microcirculation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.793
H-Index - 83
eISSN - 1549-8719
pISSN - 1073-9688
DOI - 10.1111/j.1549-8719.2000.tb00150.x
Subject(s) - chronic venous insufficiency , cell adhesion molecule , adhesion , cell adhesion , medicine , disease , chemistry , pharmacology , immunology , pathology , organic chemistry
As more insight into the mechanisms leading to chronic venous insufficiency (CVI) is gained, novel targets for drug treatment of the disease, or of its complications, become available. Studies using chemical entities capable of inhibiting leukocyte adhesion in postcapillary venules have led to the discovery of selective inhibitors of cell adhesion mechanisms. The aim of the current review is to describe the pharmacology, biochemistry, and molecular biology studies performed with some new inhibitors of adhesion molecule expression. Compounds such as hydroxy triallyl farnisine (S 17834) may offer new and efficient treatment of the microcirculatory complications that accompany chronic venous disease.